Annual report pursuant to Section 13 and 15(d)

Note 21 - Segment Information: Schedule of Segment Information (Details)

v3.21.1
Note 21 - Segment Information: Schedule of Segment Information (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cannabis and Medical Marijuana Segment    
Net sales $ 47,707 $ 158,614
Operating income (loss) (13,258) (796,232)
Interest income 0 19,745
Interest Expense 0 0
Total assets 1,042,553 1,484,877
Property additions 0 0
Depreciation, Depletion and Amortization, Nonproduction 0 0
Facilities Operations Related    
Net sales 4,778,249 4,167,858
Operating income (loss) (231,162) 74,128
Interest income 0 10
Interest Expense 34,711 26,921
Total assets 1,874,519 1,646,867
Property additions 126,396 11,766
Depreciation, Depletion and Amortization, Nonproduction 20,553 11,333
Consolidation, Eliminations    
Net sales 0 0
Operating income (loss) (829,684) (1,023,839)
Interest income 92,571 88,358
Interest Expense 584 (4,325)
Total assets 1,524,023 1,834,833
Property additions 7,593 0
Depreciation, Depletion and Amortization, Nonproduction 7,103 11,780
Net sales 4,825,956 4,326,472
Operating income (loss) (1,074,104) (1,745,943)
Interest income 92,571 108,113
Interest Expense 35,295 22,596
Total assets 4,441,095 4,966,577
Property additions 133,989 11,766
Depreciation, Depletion and Amortization, Nonproduction $ 27,656 $ 23,113